Skip to main content
Erschienen in: Journal of Cancer Survivorship 5/2021

22.10.2020

Working after cancer: in-depth perspectives from a setting with limited employment protection policies

verfasst von: Yek-Ching Kong, Negina Rauf, Shridevi Subramaniam, Ros Suzanna Bustamam, Li-Ping Wong, Gwo-Fuang Ho, Hafizah Zaharah, Matin Mellor, Cheng-Har Yip, Nirmala Bhoo-Pathy

Erschienen in: Journal of Cancer Survivorship | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A considerable proportion of individuals who are diagnosed with cancer are at a working age. We aimed to gain an in-depth understanding of the challenges, and arising needs related to working after cancer in a setting with limited employment protection policies.

Methods

Focus group discussions were conducted with cancer patients who were diagnosed at least 1 year prior to recruitment, and either had paid work, were self-employed, currently unemployed, or currently retired (N = 66).

Results

Three main themes were identified: (1) loss of income: While some participants were entitled for a 1-year cancer-specific sick leave, many other participants recounted having insufficient paid sick leave, forcing them to take prolonged unpaid leave to complete treatment; (2) dealing with side effects of cancer and its treatment: The need for workplace accommodations was highlighted including flexible working hours, lighter workloads, and dedicated rest areas to enable patients to cope better; (3) Discrimination and stigma at workplace: Some participants mentioned being passed over on a promotion, getting demoted, or being forced to resign once their cancer diagnosis was disclosed, highlighting an urgent need to destigmatize cancer in the workplace.

Conclusion

In settings with limited employment protection policies, a cancer diagnosis severely impacts the working experiences of patients, leading to financial loss. Urgent interventions and legislative reforms are needed in these settings to address the unmet employment needs of cancer survivors.

Implications for Cancer Survivors

This study may facilitate planning of local solutions to fulfill the unmet employment needs following cancer, such as return-to-work navigation services.
Literatur
1.
Zurück zum Zitat Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.CrossRef Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.CrossRef
2.
Zurück zum Zitat Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRef Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRef
3.
Zurück zum Zitat Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195–202.CrossRef Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195–202.CrossRef
4.
Zurück zum Zitat Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ. 2011;162:257–91. Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ. 2011;162:257–91.
5.
Zurück zum Zitat Kehm RD, Yang W, Tehranifar P, Terry MB. 40 years of change in age- and stage-specific cancer incidence rates in US women and men. JNCI Cancer Spectr. 2019;3(3):pkz038.CrossRef Kehm RD, Yang W, Tehranifar P, Terry MB. 40 years of change in age- and stage-specific cancer incidence rates in US women and men. JNCI Cancer Spectr. 2019;3(3):pkz038.CrossRef
6.
Zurück zum Zitat Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.CrossRef Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.CrossRef
7.
Zurück zum Zitat de Boer AG, Taskila T, Ojajärvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.CrossRef de Boer AG, Taskila T, Ojajärvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.CrossRef
8.
Zurück zum Zitat Alleaume C, Bendiane MK, Peretti-Watel P, Bouhnik AD. Inequality in income change among cancer survivors five years after diagnosis: evidence from a French national survey. PLoS One. 2019;14(10):e0222832.CrossRef Alleaume C, Bendiane MK, Peretti-Watel P, Bouhnik AD. Inequality in income change among cancer survivors five years after diagnosis: evidence from a French national survey. PLoS One. 2019;14(10):e0222832.CrossRef
9.
Zurück zum Zitat Kong YC, Wong LP, Ng CW, Taib NA, Bhoo-Pathy NT, Yusof MM, et al. Understanding the financial needs following diagnosis of breast cancer in a setting with universal health coverage. Oncologist. 2020;25(6):497–504.CrossRef Kong YC, Wong LP, Ng CW, Taib NA, Bhoo-Pathy NT, Yusof MM, et al. Understanding the financial needs following diagnosis of breast cancer in a setting with universal health coverage. Oncologist. 2020;25(6):497–504.CrossRef
10.
Zurück zum Zitat Timperi AW, Ergas IJ, Rehkopf DH, Roh JM, Kwan ML, Kushi LH. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013;22(6):1411–20.CrossRef Timperi AW, Ergas IJ, Rehkopf DH, Roh JM, Kwan ML, Kushi LH. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013;22(6):1411–20.CrossRef
11.
Zurück zum Zitat de Rijk A, Amir Z, Cohen M, Furlan T, Godderis L, Knezevic B, et al. The challenge of return to work in workers with cancer: employer priorities despite variation in social policies related to work and health. J Cancer Surviv. 2020;14(2):188–99.CrossRef de Rijk A, Amir Z, Cohen M, Furlan T, Godderis L, Knezevic B, et al. The challenge of return to work in workers with cancer: employer priorities despite variation in social policies related to work and health. J Cancer Surviv. 2020;14(2):188–99.CrossRef
15.
Zurück zum Zitat de Boer AG, Verbeek JH, Spelten ER, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–7.CrossRef de Boer AG, Verbeek JH, Spelten ER, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–7.CrossRef
16.
Zurück zum Zitat Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.CrossRef Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.CrossRef
17.
Zurück zum Zitat Lavigne JE, Griggs JJ, Tu XM, Lerner DJ. Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv. 2008;2(4):296–302.CrossRef Lavigne JE, Griggs JJ, Tu XM, Lerner DJ. Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv. 2008;2(4):296–302.CrossRef
19.
Zurück zum Zitat Alleaume C, Paraponaris A, Bendiane MK, Peretti-Watel P, Bouhnik AD. The positive effect of workplace accommodations on the continued employment of cancer survivors five years after diagnosis. Support Care Cancer. 2020;28(9):4435–43.CrossRef Alleaume C, Paraponaris A, Bendiane MK, Peretti-Watel P, Bouhnik AD. The positive effect of workplace accommodations on the continued employment of cancer survivors five years after diagnosis. Support Care Cancer. 2020;28(9):4435–43.CrossRef
20.
Zurück zum Zitat Neumark D, Bradley CJ, Henry M, Dahman B. Work continuation while treated for breast cancer: the role of workplace accommodations. Ind Labor Relat Rev. 2015;68(4):916–54.CrossRef Neumark D, Bradley CJ, Henry M, Dahman B. Work continuation while treated for breast cancer: the role of workplace accommodations. Ind Labor Relat Rev. 2015;68(4):916–54.CrossRef
21.
Zurück zum Zitat Sun W, Chen K, Terhaar A, Wiegmann DA, Heidrich SM, Tevaarwerk AJ, et al. Work-related barriers, facilitators, and strategies of breast cancer survivors working during curative treatment. Work. 2016;55(4):783–95.CrossRef Sun W, Chen K, Terhaar A, Wiegmann DA, Heidrich SM, Tevaarwerk AJ, et al. Work-related barriers, facilitators, and strategies of breast cancer survivors working during curative treatment. Work. 2016;55(4):783–95.CrossRef
22.
Zurück zum Zitat Stergiou-Kita M, Pritlove C, Kirsh B. The “Big C”-stigma, cancer, and workplace discrimination. J Cancer Surviv. 2016;10(6):1035–50.CrossRef Stergiou-Kita M, Pritlove C, Kirsh B. The “Big C”-stigma, cancer, and workplace discrimination. J Cancer Surviv. 2016;10(6):1035–50.CrossRef
23.
Zurück zum Zitat Leslie M, Strauser DR, McMahon B, Greco C, Rumrill PD Jr. The workplace discrimination experiences of individuals with cancer in the Americans with Disabilities Act Amendments Act Era. J Occup Rehabil. 2020 Mar;30(1):115–24.CrossRef Leslie M, Strauser DR, McMahon B, Greco C, Rumrill PD Jr. The workplace discrimination experiences of individuals with cancer in the Americans with Disabilities Act Amendments Act Era. J Occup Rehabil. 2020 Mar;30(1):115–24.CrossRef
24.
Zurück zum Zitat Park JH, Park JH, Kim SG, Lee KS, Hahm MI. Changes in employment status and experience of discrimination among cancer patients: findings from a nationwide survey in Korea. Psychooncology. 2010 Dec;19(12):1303–12.CrossRef Park JH, Park JH, Kim SG, Lee KS, Hahm MI. Changes in employment status and experience of discrimination among cancer patients: findings from a nationwide survey in Korea. Psychooncology. 2010 Dec;19(12):1303–12.CrossRef
25.
Zurück zum Zitat Moskowitz MC, Todd BL, Chen R, Feuerstein M. Function and friction at work: a multidimensional analysis of work outcomes in cancer survivors. J Cancer Surviv. 2014;8(2):173–82.CrossRef Moskowitz MC, Todd BL, Chen R, Feuerstein M. Function and friction at work: a multidimensional analysis of work outcomes in cancer survivors. J Cancer Surviv. 2014;8(2):173–82.CrossRef
26.
Zurück zum Zitat Greidanus MA, de Boer AGEM, de Rijk AE, Tiedtke CM, Dierckx de Casterlé B, Frings-Dresen MHW, et al. Perceived employer-related barriers and facilitators for work participation of cancer survivors: a systematic review of employers' and survivors' perspectives. Psychooncology. 2018;27(3):725–33.CrossRef Greidanus MA, de Boer AGEM, de Rijk AE, Tiedtke CM, Dierckx de Casterlé B, Frings-Dresen MHW, et al. Perceived employer-related barriers and facilitators for work participation of cancer survivors: a systematic review of employers' and survivors' perspectives. Psychooncology. 2018;27(3):725–33.CrossRef
27.
Zurück zum Zitat Tiedtke CM. Dierckx de Casterlé B, Frings-Dresen MHW, et al. Employers’ experience of employees with cancer: trajectories of complex communication. J Cancer Surviv. 2017;11(5):562–77.CrossRef Tiedtke CM. Dierckx de Casterlé B, Frings-Dresen MHW, et al. Employers’ experience of employees with cancer: trajectories of complex communication. J Cancer Surviv. 2017;11(5):562–77.CrossRef
28.
Zurück zum Zitat Feuerstein M, Gehrke AK, McMahon BT, McMahon MC. Challenges persist under Americans With Disabilities Act Amendments Act: how can oncology providers help? J Oncol Pract. 2017;13(6):e543–51.CrossRef Feuerstein M, Gehrke AK, McMahon BT, McMahon MC. Challenges persist under Americans With Disabilities Act Amendments Act: how can oncology providers help? J Oncol Pract. 2017;13(6):e543–51.CrossRef
29.
Zurück zum Zitat Tangka FK, Trogdon JG, Nwaise I, Ekwueme DU, Guy GP Jr, Orenstein D. State-level estimates of cancer-related absenteeism costs. J Occup Environ Med. 2013;55(9):1015–20.CrossRef Tangka FK, Trogdon JG, Nwaise I, Ekwueme DU, Guy GP Jr, Orenstein D. State-level estimates of cancer-related absenteeism costs. J Occup Environ Med. 2013;55(9):1015–20.CrossRef
30.
Zurück zum Zitat Hanly P, Pearce A, Sharp L. Cancer and productivity loss in the Irish economy: an employer’s perspective. Ir J Manag. 2017;36(1):5–20. Hanly P, Pearce A, Sharp L. Cancer and productivity loss in the Irish economy: an employer’s perspective. Ir J Manag. 2017;36(1):5–20.
Metadaten
Titel
Working after cancer: in-depth perspectives from a setting with limited employment protection policies
verfasst von
Yek-Ching Kong
Negina Rauf
Shridevi Subramaniam
Ros Suzanna Bustamam
Li-Ping Wong
Gwo-Fuang Ho
Hafizah Zaharah
Matin Mellor
Cheng-Har Yip
Nirmala Bhoo-Pathy
Publikationsdatum
22.10.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 5/2021
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-020-00962-z

Weitere Artikel der Ausgabe 5/2021

Journal of Cancer Survivorship 5/2021 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.